Susquehanna International Group, LLP Acorda Therapeutics Inc Call Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$1.61 - $2.5 $42,182 - $65,500	-26,200 Reduced 68.77%	11,900 $19,000
Q4 2021 Feb 14, 2022	SELL	$2.3 - $4.71 $185,610 - $380,097	-80,700 Reduced 67.93%	38,100 $91,000
Q3 2021 Nov 15, 2021	BUY	$3.36 - $4.79 $110,544 - $157,591	32,900 Added 38.3%	118,800 $546,000
Q2 2021 Aug 11, 2021	BUY	$3.61 - $5.23 $159,923 - $231,689	44,300 Added 106.49%	85,900 $410,000
Q1 2021 May 17, 2021	BUY	$3.8 - $8.04 $158,080 - $334,463	41,600 New	41,600 $203,000

133K

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.